Ryan Cohlhepp

President, COO & Interim CEO, Director, Bicara Therapeutics Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$3.5M

Companies

Latest trade

Sep 8, 2026

Companies

Bicara Therapeutics Inc.President, COO & Interim CEO, Director −$4.6M

Trades

BCAX Sold 17,500 shares at $22.90 · planned $0.4M Sep 8

BCAX Sold 18,750 shares at $27.98 · planned $0.5M Aug 10

BCAX Sold 536 shares at $29.00 · planned $0.0M Jul 9

BCAX Sold 28,214 shares at $28.98 · planned $0.8M Jul 8

BCAX Sold 12,500 shares at $20.29 · planned $0.3M May 15

BCAX Sold 12,500 shares at $23.01 · planned $0.3M Apr 15

BCAX Sold 12,500 shares at $19.66 · planned $0.2M Mar 16

BCAX Sold 17,392 shares at $18.16 · planned $0.3M Mar 3

BCAX Sold 3,631 shares at $18.04 · planned $0.1M Feb 25

BCAX Sold 3,828 shares at $18.10 · planned $0.1M Jan 22

BCAX Sold 149 shares at $18.02 · planned $0.0M Jan 15

BCAX Sold 12,500 shares at $18.68 · planned $0.2M Dec 15

BCAX Sold 12,500 shares at $18.05 · planned $0.2M Nov 21

BCAX Sold 12,500 shares at $18.16 · planned $0.2M Oct 15

BCAX Sold 10,900 shares at $18.06 · planned $0.2M Oct 7

BCAX Sold 39,600 shares at $18.06 · planned $0.7M Oct 6

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.